Drug intelligence / Profile preview

NF2 shRNA

Development stage
Preclinical
Lead developer
Aichi Cancer Center
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intraperitoneal
01

Overview

NF2 shRNA is a research-grade short hairpin RNA (shRNA) construct designed to silence the expression of the neurofibromin 2 (NF2) gene, which encodes the tumor suppressor protein Merlin. In oncological research, particularly concerning malignant mesothelioma, NF2 shRNA is utilized to model the initiation of tumors by disrupting the Hippo signaling pathway. The knockdown of NF2 leads to the dephosphorylation and subsequent nuclear translocation of Yes-associated protein (YAP), which drives the transcription of genes involved in cell proliferation and transformation. This tool is primarily employed in laboratory settings to study the molecular mechanisms of mesothelial cell transformation and to identify downstream effectors, such as PLCB4, that may serve as therapeutic targets.

Other names
neurofibromin 2 shRNAneurofibromin2 shRNAneurofibromin-2 shRNANF2 short hairpin RNANF-2 short hairpin RNANF 2 short hairpin RNAshRNA-mediated silencing of NF2
02

Targets

Neurofibromin 2 mRNA

Beyond the preview

Go deeper on NF2 shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NF2 shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call